Nita L. Seibel

Georgetown University

$34,818

Attributed

$34,818

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $27.7K · FY2005–06

$50K$37.5K$25K$12.5K$0

'05

'06

Funding mix

By agency

NIH$34,818 · 11

By mechanism

M01$34,818 · 11

Top collaborators

No co-investigators on record.

Most similar at Georgetown University

Same institution · by research overlap

Anatoly Dritschilo$2,524,432
Kevin J Cullen$20,041,785
Edward P Gelmann$8,316,737
Marc D Schwartz$16,557,279
John L. Marshall$2,076,333

Others in their field

Top investigators on “Neoplasm /Cancer Chemotherapy”

Charles A Coltman · Southwest Oncology Group$171,655,324
Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
Philip J Disaia · University Of California Irvine$41,530,194
Walter J Curran · Thomas Jefferson University$37,520,030
Samuel A Wells · Duke University$32,148,803
Gregory H Reaman · National Childhood Cancer Foundation$19,436,422

Research focus

Neoplasm /Cancer ChemotherapyDrug Screening /EvaluationPediatric Neoplasm /CancerClinical Trial Phase IiMonoclonal AntibodyClinical Trial Phase IClinical Trial Phase IiiNeoplasm /CancerNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radiation TherapyNeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer TherapyClinical ResearchNeuroblastomaPatient Oriented ResearchChronic Myelogenous LeukemiaNeoplasm /Cancer SurgeryCytokineHuman SubjectHuman Therapy Evaluation13 Cis Retinoate